The marriage of cytology and cytogenetics

Cancer Cytopathology

Volumn 121, Issue 6, 2013, Pages 279-290

  Cin, Paola Dal ^a   Qian, Xiaohua ^a   Ciba, Edmund S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytogenetics; Cytology; Fine needle aspiration; Fluorescence in situ hybridization; Karyotype

Indexed keywords

ADIPOCYTIC TUMOR; ASPIRATION CYTOLOGY; BENIGN TUMOR; BLADDER CANCER; CANCER CYTODIAGNOSIS; CANCER PROGNOSIS; CHROMOSOME ABERRATION; CYTOGENETICS; CYTOLOGY; DIAGNOSTIC ACCURACY; EPITHELIOID TUMOR; FINE NEEDLE ASPIRATION BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; KIDNEY TUMOR; LABORATORY DIAGNOSIS; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; MYXOID TUMOR; PLEOMORPHIC TUMOR; PRIORITY JOURNAL; REVIEW; SMALL ROUND BLUE CELL TUMOR; SOFT TISSUE TUMOR; SPINDLE CELL CARCINOMA; ARTICLE; CYTODIAGNOSIS; GENETICS; NEOPLASM; CANCER CLASSIFICATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; MOLECULAR DIAGNOSIS; NONHUMAN; SALIVARY GLAND CANCER; SOLID TUMOR; UROGENITAL TRACT TUMOR;

CYTODIAGNOSIS; CYTOGENETICS; HUMANS; NEOPLASMS;

EID: 84881490415     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21270     Document Type: Review

References (30)

1. Wang N. Methodologies in cancer cytogenetics and molecular cytogenetics. Am J Med Genet. 2002;115:118-124. (Pubitemid 35265500)
2. Schmitt FC, Longatto-Filho A, Valent A, Vielh P. Molecular techniques in cytopathology practice. J Clin Pathol. 2008;61:258-267. (Pubitemid 351354226)
3. Ochs RC, Bagg A. Molecular genetic characterization of lymphoma: application to cytology diagnosis. Diagn Cytopathol. 2012;40:542-555.
4. Granados R, Cibas ES, Fletcher JA. Cytogenetic analysis of effusions for malignant mesothelioma: a diagnostic adjunct to cytology. Acta Cytol. 1994;38:711-717. (Pubitemid 24293416)
5. Kilpatrick SE, Bergman S, Pettenati MJ, Gulley ML. The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas. Mod Pathol. 2006;19:815-819. (Pubitemid 43780451)
6. Oliveira AM, French CA. Applications of fluorescence in situ hybridization in cytopathology: a review. Acta Cytol. 2005;49: 587-594. (Pubitemid 41667074)
7. Heim S, Mitelman F. Cancer Cytogenetics. 3rd ed. New York: John Wiley & Sons; 2009.
8. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer [database online]. Available at: http://cgap.nci.nih.gov/ Chromosomes/Mitelman. Accessed October 30, 2012.
9. Qian X. Soft tissue. In: Cibas ES, Ducatman BS, eds. Cytology: Diagnostic Principles and Clinical Correlates. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2009:451-494.
10. Ladanyi M, Antonescu C, Dal Cin P. Cytogenetic and molecular genetic pathology of soft tissue tumors. In: Weiss S, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 5th ed. Philadelphia, PA: Mosby Elsevier; 2008:73-102.
11. Qian X, Hornick JL, Cibas ES, Dal Cin P, Domanski HA. Angiomatoid fibrous histiocytoma a series of 5 cytologic cases with literature review and emphasis on diagnostic pitfalls. Diagn Cytopathol. 2012;40(suppl 2):E86-E93.
12. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347. (Pubitemid 41368770)
13. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21:943-949.
14. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008;32:8-13.
15. Jakowski JD, Wakely PE Jr. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer (Cancer Cytopathol). 2007;111:298-305.
16. Thway K, Fisher C. Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status [serial online]. Am J Surg Pathol. 2012;36:e1-e11.
17. Kang SH, Perle MA, Nonaka D, Zhu H, Chan W, Yang GC. Primary Ewing sarcoma/PNET of the kidney: fine-needle aspiration, histology, and dual color break apart FISH Assay. Diagn Cytopathol. 2007;35:353-357. (Pubitemid 46835026)
18. Klijanienko J, Couturier J, Bourdeaut F, et al. Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/ peripheral neuroectodermal tumor. Institut Curie's experience. Diagn Cytopathol. 2012;40:19-25.
19. Bentz JS, Rowe LR, Anderson SR, Gupta PK, McGrath CM. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material. Cancer (Cancer Cytopathol). 2004;102: 124-131. (Pubitemid 38489970)
20. Richmond J, Bryant R, Trotman W, Beatty B, Lunde J. FISH detection of t(14;18) in follicular lymphoma on Papanicolaoustained archival cytology slides. Cancer (Cancer Cytopathol). 2006;108:198-204.
21. Elkins CT, Wakely PE Jr. Cytopathology of "double-hit" non-Hodgkin lymphoma. Cancer (Cancer Cytopathol). 2011;119: 263-271.
22. Roh MH, Dal Cin P, Silverman SG, Cibas ES. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms. Cancer (Cancer Cytopathol). 2010;118:137-145.
23. Beroukhim R, Brunet JP, Di Napoli A, et al. Patterns of gene expression and copy-number alterations in von-Hippel Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 2009;69:4674-4681.
24. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet. 2001; 130:1-7. (Pubitemid 32982126)
25. Factor RE, Dal Cin P, Fletcher JA, Cibas ES. The value of cytogenetics and molecular cytogenetics as adjuncts to cytology in the diagnosis of malignant mesothelioma in pleural and peritoneal fluids [abstract]. Mod Pathol. 2008;21:72A.
26. Meloni AM, Peier AM, Haddad FS, et al. A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Genet Cytogenet. 1993;71: 105-118.
27. Sandberg AA. Cytogenetics and molecular genetics of bladder cancer: a personal view. Am J Med Genet. 2002;115:173-182. (Pubitemid 35265507)
28. Sarosdy MF, Kahn PR, Ziffer MD, et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol. 2006;176:44-47. (Pubitemid 43833178)
29. Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol. 2002;168:1950-1954.
30. Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003;169:2101-2105. (Pubitemid 36576726)